Mona Shing

Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER

Adam Brufsky, Musa Mayer, Hope S. Rugo et al. · Clinical Cancer Research · 2011 · 400 citations

Medicine, Oncology, Breast Oncology +16

Phase I Study of GRN1005 in Recurrent Malignant Glioma

Jan Drappatz, Andrew Brenner, Eric T. Wong et al. · Clinical Cancer Research · 2013 · 181 citations

Medicine, Oncology, Pharmacology +17

HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Manish A. Shah, Rui‐Hua Xu, Yung‐Jue Bang et al. · Journal of Clinical Oncology · 2017 · 117 citations

Medicine, Oncology, Pharmacology +17

Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)

Edith A. Perez, Michael F. Press, Amylou C. Dueck et al. · Breast Cancer Research and Treatment · 2013 · 81 citations · Full text

Medicine, Cancer Biology, Oncology +14

HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant–adjuvant trastuzumab after 2 years of treatment-free follow-up

Christian Jackisch, Roberto Hegg, Daniil Stroyakovskiy et al. · European Journal of Cancer · 2016 · 78 citations · Full text

Medicine, Oncology, Pharmacology +12